D.A. Davidson & Co.
- SEC CIK
- 0001080107
- Latest filing
- Jul 24, 2026
AVXL holding history
Anavex Life Sciences Corp. in every 13F filed by D.A. Davidson & Co., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
AVXL overviewAll 13F holders of AVXLFull Q2 2026 holdings
- Shares (Q2 2025)
- 0
- Sold out in Q2 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 4
- Since Q4 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2025 | 0 | $0 | 0.0% | −10,335−100.0% | Sold out | Holders |
| Q1 2025 | 10,335 | $88.7K | <0.1% | −1,050−9.2% | Reduced | Holders |
| Q4 2024 | 11,385 | $122.3K | <0.1% | +11,385 | New | Holders |
| Q2 2024 | 0 | $0 | 0.0% | −13,770−100.0% | Sold out | Holders |
| Q1 2024 | 13,770 | $70.1K | <0.1% | +2,520+22.4% | Added | Holders |
| Q4 2023 | 11,250 | $104.7K | <0.1% | +11,250 | New | Holders |